- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Natco Pharma Limited — Updates, 21-11-2025: Press Release
21-11-2025 | 04:15 pm
21-11-2025 | 04:15 pm
NATCO Pharma's Manali API unit concluded a US FDA inspection, receiving seven Form-483 observations. The company believes these are procedural and is confident in addressing them, affirming commitment to cGMP and product quality.
No comments yet. Be the first to comment!